# Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear

> **NCT00691197** · PHASE2,PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 246 (actual)

## Conditions studied

- Ametropia

## Interventions

- **DEVICE:** Carboxymethylcellulose sodium and Glycerin
- **DEVICE:** Carboxymethylcellulose sodium

## Key facts

- **NCT ID:** NCT00691197
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2015-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691197, "Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00691197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*